Casi Pharmaceuticals Inc Expected To Post A Loss Of 5 Cents A Share: Earnings Preview

CASI Pharmaceuticals

10/11/2021 14:06

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 12. 
* The Rockville, Maryland-based company is expected to report  a
77.7% increase in revenue to $7.539 million from $4.24 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for CASI Pharmaceuticals
Inc is for a loss of 5 cents per share. For the same quarter
last year, the company reported a loss of 14 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $4​, about 73% above​ its last closing
price of $1.08. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.08       -0.07      -0.05     Beat    31
 Mar. 31 2021  -0.06       -0.06      -0.11     Missed  -83.3
 Dec. 31 2020              -0.07      -0.12     Missed  -71.4​
 Sep. 30 2020  -0.06       -0.05      -0.14     Missed  -154.5
 ​​Jun.        -0.08       -0.08      -0.07     Beat    12.5
 30 2020                                                
 Mar. 31 2020              -0.11      -0.09     Beat    18.2​
 Dec. 31 2019              -0.11      -0.12     Missed  -9.1
 Sep. 30 2019  -0.11       -0.11      -0.10     Beat    9.1
 This summary was machine generated November 10 at 14:06 GMT. 
All figures in US dollars  unless otherwise stated